Latest News and Press Releases
Want to stay updated on the latest news?
-
Draupnir Bio completes €12 million seed round to progress development of oral small molecule degraders of extracellular proteins MP Healthcare and EIFO join existing investors, Gilde Healthcare...
-
Press Release Draupnir Bio establishes Scientific Advisory Board of European experts in cholesterol metabolism and cardiovascular disease Copenhagen, Denmark, 23 September 2021 – Draupnir Bio...
-
Press Release Draupnir Bio establishes Scientific Advisory Board of European experts in cholesterol metabolism and cardiovascular disease Copenhagen, Denmark, 23 September 2021 – Draupnir Bio...
-
Press Release Draupnir Bio strengthens senior management with the appointment of Anna Quattropani as Chief Discovery Officer Copenhagen, Denmark, 12 July 2021 – Draupnir Bio (“Draupnir”), a...
-
Press Release Draupnir Bio strengthens senior management with the appointment of Anna Quattropani as Chief Discovery Officer Copenhagen, Denmark, 12 July 2021 – Draupnir Bio (“Draupnir”), a...
-
Press Release Andrew Hotchkiss joins Draupnir Bio as Chief Executive Officer Copenhagen and Aarhus, Denmark, 23 June 2021 – Draupnir Bio (“Draupnir”), a biotechnology company developing small...
-
Press Release Andrew Hotchkiss joins Draupnir Bio as Chief Executive Officer Copenhagen and Aarhus, Denmark, 23 June 2021 – Draupnir Bio (“Draupnir”), a biotechnology company developing small...